IP Library Granted Patent US 10,544,453
Granted Patent B2
US 10,544,453 · App. 14/339,092 · Granted Jan 28, 2020

Method for detecting nucleic acid amplification product in real time

Inventors: Yuichi Tamaoki (Gunma, JP); Akifumi Iwama (Tsukuba, JP); Yasuaki Sonoda (Gunma, JP)
Assignee: PHC HOLDINGS CORPORATION
C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,544,453
App. No.
14/339,092
Granted
Jan 28, 2020
Kind
B2
Abstract

There is provided an apparatus for detecting a nucleic acid amplification product in real time, which is capable of effectively excluding or reducing apparatus error factors without using a second fluorescence signal used for correction. A plurality of wells 7 A are given with temperature cycles and fluorescence strength from a nucleic acid amplification product is detected in real time in each well 7 A. A fluorescence measurement value [DNA]raw obtained from the well 7 A and a fluorescence measurement value [DNA]bg obtained from a connection wall near the well 7 A are detected, and the fluorescence measurement value [DNA]bg is subtracted from the fluorescence measurement value [DNA]raw to determine fluorescence strength [DNA]real of the well 7 A.

Claims (10)

1. A method for detecting fluorescence strength from a nucleic acid amplification product in real time in each of a plurality of reaction regions in a reaction vessel undergoing temperature cycling, comprising the steps of:

subjecting a reaction vessel having a plurality of reaction regions oriented in a rectangular array, to temperature cycling;

after a temperature cycle, detecting, using an optical system fluorescence measurement, separately for each of the reaction regions in the reaction vessel:

a value [DNA]raw from the reaction region; and

a fluorescence measurement value [DNA]bg, obtained from four separate regions, each of which is outside the reaction region and in a connection wall portion adjacent to the reaction region; and

subtracting the fluorescence measurement value [DNA]bg from the fluorescence measurement value [DNA]raw every time the fluorescence measurement value [DNA]raw is detected for each of the reaction regions separately to determine fluorescence strength [DNA]real of each of the reaction regions.

2. The method according to claim 1 ,

wherein the detecting and subtracting steps are performed after each temperature cycle.

3. The method according to claim 1 ,

wherein, in the detecting step, for each reaction region, the fluorescence measurement value [DNA]bg for the reaction region is a simple average value or a weighted average value of the four fluorescence measurement values from the four separate regions for that reaction region.

Assignments (4)
CHANGE OF NAME Recorded May 18, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046185/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2016
From: PANASONIC HEALTHCARE CO., LTD.
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 037777/0618 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2014
From: SANYO ELECTRIC CO., LTD.
To: PANASONIC HEALTHCARE CO., LTD.
Reel/Frame 033610/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2014
From: TAMAOKI, YUICHI; IWAMA, AKIFUMI; SONODA, YASUAKI
To: SANYO ELECTRIC CO., LTD.
Reel/Frame 033573/0399 →
Priority Claims (1)
JP 2006-059381 · Mar 6, 2006 · national
Continuity (2)
Division 12281540
Related Publication 20140335531A1 · Nov 13, 2014